SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORTESI, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.449
AS - Asia 7.785
EU - Europa 4.652
SA - Sud America 1.391
AF - Africa 116
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.165
SG - Singapore 3.180
CN - Cina 2.267
BR - Brasile 1.162
IT - Italia 1.071
UA - Ucraina 969
HK - Hong Kong 765
DE - Germania 697
GB - Regno Unito 553
TR - Turchia 500
VN - Vietnam 344
SE - Svezia 273
FI - Finlandia 272
RU - Federazione Russa 232
IN - India 188
PL - Polonia 150
MX - Messico 138
CA - Canada 115
ID - Indonesia 107
FR - Francia 98
AR - Argentina 91
JP - Giappone 73
NL - Olanda 64
AT - Austria 53
ZA - Sudafrica 53
BD - Bangladesh 51
IQ - Iraq 50
ES - Italia 38
EC - Ecuador 35
LT - Lituania 35
TH - Thailandia 34
BE - Belgio 33
KR - Corea 32
PK - Pakistan 32
CO - Colombia 29
RO - Romania 23
IL - Israele 20
IR - Iran 20
CL - Cile 17
VE - Venezuela 16
JO - Giordania 15
CH - Svizzera 14
CZ - Repubblica Ceca 13
PE - Perù 13
SA - Arabia Saudita 13
EG - Egitto 12
PH - Filippine 12
PY - Paraguay 11
UY - Uruguay 11
KE - Kenya 10
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
DZ - Algeria 8
LV - Lettonia 8
MA - Marocco 8
AL - Albania 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
PT - Portogallo 7
TW - Taiwan 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BF - Burkina Faso 6
KW - Kuwait 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
OM - Oman 5
TN - Tunisia 5
GT - Guatemala 4
IE - Irlanda 4
MD - Moldavia 4
NG - Nigeria 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
HN - Honduras 3
HU - Ungheria 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 30.389
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.701
Singapore 1.692
Fairfield 1.646
Ashburn 1.588
Houston 1.257
Jacksonville 1.068
Chandler 897
Santa Clara 879
Beijing 755
Hong Kong 749
Ann Arbor 691
Seattle 657
Wilmington 607
Cambridge 574
Izmir 341
Ferrara 314
Nanjing 287
Princeton 248
Los Angeles 227
Dallas 224
New York 190
Boardman 183
Ho Chi Minh City 149
Warsaw 134
San Diego 128
Munich 119
São Paulo 114
Shanghai 103
Mexico City 95
Shenyang 89
Milan 86
Nanchang 84
Jakarta 73
Hefei 72
Dearborn 70
London 65
Hanoi 62
Buffalo 60
Jiaxing 60
Hebei 58
Brooklyn 57
Chicago 57
Changsha 56
Tokyo 56
Redwood City 51
Montreal 48
Tianjin 47
Moscow 45
Bologna 43
Boston 41
Helsinki 40
Rio de Janeiro 40
Vienna 39
Chennai 38
Turku 37
Falkenstein 35
Stockholm 35
Council Bluffs 34
Denver 33
Jinan 33
San Francisco 33
Brussels 32
Norwalk 32
Mountain View 31
San Mateo 31
Belo Horizonte 30
Frankfurt am Main 30
Johannesburg 30
Ningbo 29
Falls Church 28
Poplar 28
Addison 27
The Dalles 27
Toronto 27
Atlanta 26
Ankara 25
Indiana 22
Mumbai 22
Orange 22
Zhengzhou 22
Kunming 21
Manchester 21
Amsterdam 20
Auburn Hills 20
Ferrara di Monte Baldo 20
Orem 20
Rome 20
Verona 20
Washington 19
Columbus 18
Hangzhou 18
Porto Alegre 17
Baghdad 16
Curitiba 16
Guangzhou 16
New Delhi 16
Phoenix 16
Salvador 16
Charlotte 15
Des Moines 15
Totale 20.175
Salva come PNG Salva come JPEG
Nome #
Structural studies of lipid based nanosystems for drug delivery: X-Ray Diffraction (XRD) and Cryogenic Transmission Electron Microscopy (cryo-TEM) 367
Biodistribution of nanostructured lipid carriers: a tomographic study 277
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 237
Skin care: The innovative nanotechnology to improve the performance of delivery systems 225
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 224
Aminated polysaccharide microspheres as DNA delivery systems 210
Acyclovir delivery systems 208
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 207
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 204
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 201
Amphiphilic association systems for amphotericin B delivery 198
Cationic lipospheres as delivery systems for nucleic acid molecules 196
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 193
Cationic lipid nanosystems as carriers for nucleic acids 192
Analysis of the drug release profiles from formulations based on micro and nano systems 190
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 187
Design and characterization of ethosomes for transdermal delivery of caffeic acid 185
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies 185
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 183
Amphiphilic association systems for Amphotericin B delivery 182
Clotrimazole Nanoparticle gel for mucosal administration. 182
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 181
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 180
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 178
Design and characterization of fenretinide containing organogels 176
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 176
Progesterone lipid nanoparticles: Scaling up and in vivo human study 176
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 174
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 174
Microparticles containing gallic and ellagic acids for the biological control of bacterial diseases of kiwifruit plants 173
Ethosomes and organogels for cutaneous administration of crocin 171
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 171
Production of lipospheres as carriers for bioactive compounds 170
Liposomes as carriers for DNA-PNA hybrids 169
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 168
Gelified reverse micellar dispersions as percutaneous formulations 167
Cationic lipid nanosystems as carriers for nucleic acids 167
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.) 165
Gallic acid loaded poloxamer gel as new adjuvant strategy for melanoma: A preliminary study 164
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 164
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 163
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 162
L-dopa co-drugs in nanostructured lipid carriers: a comparative study 162
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 162
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation 162
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 161
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 160
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 159
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 159
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 159
Monoolein Aqueous Dispersions as a delivery system for quercetin 159
Microparticles as delivery systems for local delivery to the oral cavity. 158
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 156
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 156
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 155
Influence of formulation and process parameters on pellet production by powder layering technique 154
Investigation of the bioequivalence of Rosuvastatin 20 mg tablets after a single oral administration in mediterranean arabs using a validated LC MS/MS method 154
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 154
Curcumin containing monoolein aqueous dispersions: a preformulative study 153
Nanosistemi lipidici per la veicolazione di acidi nucleici 153
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 153
Eudragit® microparticles for the release of budesonide: A comparative study 153
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 152
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 152
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 151
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 151
Budesonide microparticles for the treatment of Crohn's disease 150
In vitro effect on human leukemic K562 cells of co-administration of liposome-associated retinoids and cytosine arabinoside (Ara-C) 149
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 149
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 149
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 147
Pharmaceutical and biotechnological applications of multiple emulsions 147
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 146
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation 146
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 146
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 145
Polymeric microparticles for fenretinide administration 145
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 144
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 144
Lipid-based supramolecular systems for topical application: A preformulatory study 144
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 144
Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol 143
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 143
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 143
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 142
Evaluation of percutaneous absorption of naproxen from different liposomal formulations 141
Spray dried Eudragit microparticles as encapsulation devices for vitamin C 139
Tailor-made core-shell nanospheres for antisense oligonucleotide delivery: IV. Adsorption/release behaviour 139
Production of Eudragit microparticles by spray-drying technique: Influence of experimental parameters on morphological and dimensional characteristics 139
Sugar cross-linked gelatin for controlled release: microspheres and disks 139
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 139
Preparation and characterization of cationic microspheres for gene delivery 139
Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes 138
In vitro antiproliferative activity of isothiocyanates and nitriles generated by myrosinase-mediated hydrolysis of glucosinolates from seeds of cruciferous vegetables 138
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 138
Dextran cross-linked gelatin microspheres as a drug delivery system 138
Macrophages loaded with doxorubicin by ATP-mediated permeabilization: potential carriers for antitumor therapy 137
Distamycins: strategies for possible enhancement of activity and specificity 137
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 137
Cationic phosphines for the obtaining of non-viral vectors 137
Totale 16.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.331
Totale 156.605
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.994 0 0 0 0 0 339 162 383 76 471 362 201
2021/20222.239 106 276 172 123 63 110 122 148 74 208 210 627
2022/20232.222 257 75 69 256 369 376 72 212 293 18 149 76
2023/20241.229 147 150 58 35 91 247 68 67 20 38 54 254
2024/20255.258 157 122 422 163 708 531 131 389 911 483 787 454
2025/20267.275 1.330 697 1.261 1.891 1.885 211 0 0 0 0 0 0
Totale 30.803